Authors:
Bailly, C
Goossens, JF
Laine, W
Anizon, F
Prudhomme, M
Ren, JS
Chaires, JB
Citation: C. Bailly et al., Formaldehyde-induced alkylation of a 2 '-aminoglucose rebeccamycin derivative to both A center dot T and G center dot C base pairs in DNA, J MED CHEM, 43(24), 2000, pp. 4711-4720
Authors:
Bailly, C
Qu, XG
Graves, DE
Prudhomme, M
Chaires, JB
Citation: C. Bailly et al., Calories from carbohydrates: energetic contribution of the carbohydrate moiety of rebeccamycin to DNA binding and the effect of its orientation on topoisomerase I inhibition, CHEM BIOL, 6(5), 1999, pp. 277-286
Citation: Js. Ren et al., Spectral and physical characterization of the inverted terminal repeat DNAstructure from adenoassociated virus 2, NUCL ACID R, 27(9), 1999, pp. 1985-1990
Authors:
Qu, XG
Chaires, JB
Ohkubo, M
Yoshinari, T
Nishimura, S
Bailly, C
Citation: Xg. Qu et al., A DNA binding indolocarbazole disaccharide derivative remains highly cytotoxic without inhibiting topoisomerase I, ANTI-CAN DR, 14(5), 1999, pp. 433-442
Authors:
Bailly, C
Qu, XG
Anizon, F
Prudhomme, M
Riou, JF
Chaires, JB
Citation: C. Bailly et al., Enhanced binding to DNA and topoisomerase I inhibition by an analog of theantitumor antibiotic rebeccamycin containing an amino sugar residue, MOLEC PHARM, 55(2), 1999, pp. 377-385
Authors:
Bailly, C
Qu, XG
Chaires, JB
Colson, P
Houssier, C
Ohkubo, M
Nishimura, S
Yoshinari, T
Citation: C. Bailly et al., Substitution at the F-ring N-imide of the indolocarbazole antitumor drug NB-506 increases the cytotoxicity, DNA binding, and topoisomerase I inhibition activities, J MED CHEM, 42(15), 1999, pp. 2927-2935
Citation: Ch. Spink et Jb. Chaires, Effects of hydration, ion release, and excluded volume on the melting of triplex and duplex DNA, BIOCHEM, 38(1), 1999, pp. 496-508